Journal profile · Medicine, Research & Experimental
Xenotransplantation
ISSN 0908-665X · eISSN 1399-3089 · Wiley-Blackwell Publishing Ltd · DENMARK · Quarterly · Founded 1994
Xenotransplantation: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 3.42; hybrid open access; APC about USD 4,550; median 125 days to acceptance (59 articles, last 24 months); community-reported acceptance: fairly easy; 100 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Xenotransplantation is published by Wiley-Blackwell Publishing Ltd and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Xenotransplantation and immune response, Animal Genetics and Reproduction and Organ Transplantation Techniques and Outcomes, together about 52.8% of its articles. Its main subfields are Surgery. (generated from OpenAlex topic counts and CAS ranking data)
Submit your manuscript submissions to Xenotransplantation online at http://mc.manuscriptcentral.com/xen Xenotransplantation provides its readership with rapid communication of new findings in the field of organ and tissue transplantation across species barriers.The journal is not only of interest to those whose primary area is xenotransplantation, but also to veterinarians, microbiologists and geneticists. It also investigates and reports on the controversial theological, ethical, legal and psychological implications of xenotransplantation. Unsolicited contributions of full length and brief communications dealing with both basic and applied studies in this field will be considered for publication pending scientific review to assure high quality. In addition, review articles of timely subjects will be solicited by the editors. While xenotransplantation still has a considerable way to go before it becomes a clinical reality, researchers remain confident that new advances are steadily bringing that day closer. Xenotransplantation is the journal for all those who wish to stay at the forefront of this fast developing and emerging field.
From the journal's Aims & Scope
Research area (LetPub): Medicine, Research & Experimental
Editor-in-chief Leo H. BühlerPublisher website
Editorial board by country: 8 in mainland China (about 13%); most named United States 24, Mainland China 8, Switzerland 7, Germany 4, United Kingdom 2 (60 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Xenotransplantation and immune responseMedicine33.8%
- Animal Genetics and ReproductionBiochemistry, Genetics and Molecular Biology9.7%
- Organ Transplantation Techniques and OutcomesMedicine9.3%
- Tissue Engineering and Regenerative MedicineMedicine7.2%
- Pancreatic function and diabetesMedicine7.1%
- Virus-based gene therapy researchBiochemistry, Genetics and Molecular Biology5.5%
- T-cell and B-cell ImmunologyImmunology and Microbiology3.5%
- Organ and Tissue Transplantation ResearchMedicine2.3%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Medicine, Research & Experimental | Zone 4 |
| Minor | Transplantation | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Medicine, Research & Experimental | Zone 3 |
| Minor | Transplantation | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Medicine, Research & Experimental | Zone 4 |
| Minor | Transplantation | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
MEDLINEPubMedEmbaseCAB AbstractsCurrent ContentsPublisher website
Other: EBSCO
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 3.42LetPub ·
- Impact factor (publisher)
- 3.8Publisher website ·
- Impact factor (publisher) 2025
- 3.8Publisher website ·
- CiteScore 2026-06
- 5.4LetPub ·
- CiteScore (publisher)
- 5.4Publisher website ·
- CiteScore (publisher) 2025
- 5.4Publisher website ·
- SJR 2026-06
- 0.99LetPub ·
- SNIP 2026-06
- 0.88LetPub ·
- h-index
- 56LetPub ·
- h-index
- 82OpenAlex ·
- i10-index
- 1,023OpenAlex ·
- 2-year mean citedness
- 2.46OpenAlex ·
- Self-citation rate
- 36.8%LetPub ·
- Share of gold OA articles
- 39.55%LetPub ·
Volume
- Articles per year
- 67LetPub ·
- Articles per year (publisher) 2025
- 75Publisher website ·
- Downloads per year (publisher) 2025
- 127,558Publisher website ·
Articles by year OpenAlex count · 2,745 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 69 | 34 | 21 |
| 2025 | 100 | 55 | 296 |
| 2024 | 55 | 35 | 233 |
| 2023 | 77 | 36 | 428 |
| 2022 | 66 | 33 | 599 |
| 2021 | 63 | 20 | 614 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
125 daysMedian, submission to acceptance · P25–P75 71 days – 192 days
- Acceptance to online
- median 18 days (60 articles)
- Submission to online
- median 147 days
- Sample
- 59 articles with submission and acceptance dates (162 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- over 12 weeksLetPub ·
- Average acceptance (community reports)
- Fairly easyLetPub ·
- Acceptance rate (publisher)
- 60%Publisher website ·
- Acceptance rate (publisher) 2025
- 60%Publisher website ·
- Submission to first decision
- 39 daysPublisher website ·
- Submission to first decision 2025
- 39 daysPublisher website ·
- Submission to acceptance 2025
- 124 daysPublisher website ·
- Acceptance to publication 2025
- 24 daysPublisher website ·
- Peer review
- Single-anonymous peer reviewPublisher website · model-extracted
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 4,550 / EUR 3,810 / GBP 3,020 | — | — | |
| Publisher website | Yes, amount not published | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare10 items from the author guidelines
- Abstract
- ≤ 250 words
- Keywords
- ≤ 7
- Manuscript length
- ≤ 3,000 words
- Reference style
- Numbered, in order of citation
- Templates
- LaTeX and Word
- First submission
- Free format: the journal's layout is not required
- Suggested reviewers
- Required
- Highlights
- Required
- Graphical abstract
- Required
- Cover letter
- Required
Article types accepted8, with length limits
- book reviewCommentaries consist of brief revies and opinions on a topic of interast in Xenotransplantation, and should generally not exceed 1,000 words. The editors welcom…Length not stated
- brief communicationCommentaries consist of brief revies and opinions on a topic of interast in Xenotransplantation, and should generally not exceed 1,000 words. The editors welcom…main text ≤ 2,500 words
- commentaryCommentaries consist of brief revies and opinions on a topic of interast in Xenotransplantation, and should generally not exceed 1,000 words. The editors welcom…Length not stated
- letters to the editorCommentaries consist of brief revies and opinions on a topic of interast in Xenotransplantation, and should generally not exceed 1,000 words. The editors welcom…Length not stated
- opinionCommentaries consist of brief revies and opinions on a topic of interast in Xenotransplantation, and should generally not exceed 1,000 words. The editors welcom…main text ≤ 1,000 words
- original paperCommentaries consist of brief revies and opinions on a topic of interast in Xenotransplantation, and should generally not exceed 1,000 words. The editors welcom…Length not stated
- rapid communicationCommentaries consist of brief revies and opinions on a topic of interast in Xenotransplantation, and should generally not exceed 1,000 words. The editors welcom…Length not stated
- reviewCommentaries consist of brief revies and opinions on a topic of interast in Xenotransplantation, and should generally not exceed 1,000 words. The editors welcom…Length not stated
Policy excerpts from the journal's websiteAuthorship, Conflicts of interest, Data availability, Publication ethics, Peer review, Trial registration / reporting guidelines
- Authorship Authorship
Please refer to the 'Editorial Policies and Ethical Considerations' section for details on author listing eligibility.
Source ↗Publisher website ·- Conflicts of interest Conflict of Interest Statement
Authors will be asked to provide a conflict of interest statement during the submission process. For details on what to include in this section, see the 'Editorial Policies and Ethical Considerations' section below. Submitting authors should ensure they liaise with all co-authors to confirm agreement with the final statement.
Source ↗Publisher website ·- Data availability Data Sharing and Data Accessibility
The journal expects that data supporting the results in the paper will be archived in an appropriate public repository. Whenever possible the scripts and other artefacts used to generate the analyses presented in the paper should also be publicly archived. Exceptions may be granted at the discretion of the editor for sensitive information such as human subject data or the location of endangered sp…
Source ↗Publisher website ·- Publication ethics 5. EDITORIAL POLICIES AND ETHICAL CONSIDERATIONS
Member of COPE Model summary
Peer Review and Acceptance The acceptance criteria for all papers are the quality and originality of the research and its significance to journal readership. Except where otherwise stated, manuscripts are peer reviewed. Papers will only be sent to review if the Editor-in-Chief determines that the paper meets the appropriate quality and relevance requirements. Wiley's policy on the confidentiality …
Source ↗Publisher website ·- Peer review 1. TRANSPLANT PEER REVIEW NETWORK
This journal participates in the Wiley Transplant Peer Review Network (Tx PRN), a consortium formed to simplify the publication process for authors and reduce the time and effort involved in the peer review of transplantation research. The goals of the Tx PRN are to support efficient and thorough peer review, to ease the burden on peer reviewers, and to improve the publication process for authors.…
Source ↗Publisher website ·- Trial registration / reporting guidelines Clinical Trial Registration
The journal requires that clinical trials are prospectively registered in a publicly accessible database and clinical trial registration numbers should be included in all papers that report their results. Authors are asked to include the name of the trial register and the clinical trial registration number at the end of the abstract. If the trial is not registered, or was registered retrospectivel…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Wiley-Blackwell Publishing Ltd
- Country or region
- DENMARK
- Language
- English
- Frequency
- Quarterly
- Founded
- 1994
- ISSN
- 0908-665X
- Electronic ISSN
- 1399-3089
- Society / sponsor
- International Xenotransplantation Association
- Latest issue on the website
- Volume 33, Issue 5 (October 2026)
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Xenotransplantation
What CAS zone is Xenotransplantation in?
In the 2025 upgraded edition of the CAS Journal Ranking, Xenotransplantation is in Zone 4 of Medicine, and in Zone 4 of the minor category Medicine, Research & Experimental / Transplantation. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Xenotransplantation?
The latest impact factor listed by LetPub is 3.42; CiteScore 5.4, h-index 82.
How long does peer review take at Xenotransplantation?
Based on the dates recorded on 59 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 125 days (interquartile range 71–192 days); authors report an average review time of over 12 weeks; the community-reported acceptance is “Fairly easy”; the journal's website gives an acceptance rate of 60% (2025). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Xenotransplantation?
According to the journal's author guidelines: Abstract: ≤ 250 words; Keywords: ≤ 7; Manuscript length: ≤ 3,000 words; Reference style: Numbered, in order of citation; Templates: LaTeX and Word; First submission: Free format: the journal's layout is not required; Suggested reviewers: Required; Highlights: Required; Graphical abstract: Required; Cover letter: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Xenotransplantation based?
Of the 60 board members whose country the journal's board page names, 8 (about 13%) are in mainland China; the countries named most often are United States (24), Mainland China (8) and Switzerland (7). Counted from the institutions listed on the board page; for reference only.
Which databases index Xenotransplantation?
According to LetPub and DOAJ records, Xenotransplantation is indexed in SCIE and Scopus. The journal's website also lists MEDLINE, PubMed, Embase, CAB Abstracts and Current Contents; that list has not been checked against each database.
Is Xenotransplantation open access, and what is the APC?
Xenotransplantation is a hybrid journal. For open-access publication: APC about USD 4,550.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .